article thumbnail

The Potential Value Industry Leaders See in the Autonomous Pharmacy

Omnicell

It has developed a framework that identifies five levels of increasing technological capability and work process improvement spanning nine pharmacy work processes. The ultimate goal is near error-free medication management that optimizes the benefits and minimizes the harm and costs of medication use.

article thumbnail

Consistent Measurements from Lab-to-Process Improve Production

ISPE

Consistent Measurements from Lab-to-Process Improve Production. Consistent Measurements from Lab-to-Process Improve Production. Labs are then used to provide quality control monitoring as promising drugs move through process development on a pilot scale, followed by non-GMP and then GMP manufacturing. Company Name.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Avoid CMC Challenges by Thinking Slow, Not Fast-Discussions at USP’s Workshop

The FDA Law Blog

The bar for demonstrating comparability is high if a manufacturing change is introduced in the middle of a Phase 2 pivotal study versus if a sponsor introduces a process improvement between Phase 1 and before starting the Phase 2 pivotal study. Release testing alone is not sufficient.

FDA 57
article thumbnail

A Proposal for a Comprehensive Quality Overall Summary

ISPE

Ultimately, the summary was not adopted during the QbD pilot, but was reintroduced in 2014 when a Pharmaceutical Research and Manufacturers of America (PhRMA) team prepared a white paper describing the content and format of an improved Module 2. July–August 2020).

article thumbnail

A Proposal for a Comprehensive Quality Overall Summary

ISPE

Ultimately, the summary was not adopted during the QbD pilot, but was reintroduced in 2014 when a Pharmaceutical Research and Manufacturers of America (PhRMA) team prepared a white paper describing the content and format of an improved Module 2. July–August 2020).

article thumbnail

Considerations for a Decentralized Manufacturing Paradigm

ISPE

EFPIA White Paper on CMC Development, Manufacture and Supply of Pandemic COVID-19 Therapies and Vaccines.” AI Technology There are multiple potential future applications of AI technology that can support more efficient technology transfer, scale-up, site monitoring, and regulatory submission processes (see Figure 2).

article thumbnail

Streamlining Postapproval Submissions Using ICH Q12 & SCDM

ISPE

Following approval of an initial marketing application, postapproval changes are needed to ensure adequate supply, mitigate supply risk, expand patient market access, optimize manufacturing processes, improve analytical methods, and comply with new regulatory expectations. Accumulus Synergy White Paper. 2021.09.046.